Osterweis Capital Management reviews Q3 2025 small cap growth trends, highlighting AI tailwinds, key exits, and standout ...
The AI tool primarily uses information from the mammogram, including tumor features and breast density, to make a risk ...
DenseWolf-K, a hybrid AI framework, achieved 99.64% accuracy in brain tumour MRI classification, revolutionising medical ...
Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...
Guardant Health, Inc. shows strong adoption and revenue growth in oncology and data. Click for my updated look at GH stock ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify ...
The Amazon layoffs bloodbath has arrived. 30,000 corporate staff face the AI-driven White-Collar Recession. We detail the ...
Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify ...